![What’s Next for the UK’s Subscription Model in the Fight Against Antimicrobial Resistance](/sites/default/files/oembed_thumbnails/GW-yGkSgZuyx0nTQoL3eA8AeXZGsfTmuBIL9PCQXgq0.jpg)
What’s Next for the UK’s Subscription Model in the Fight Against Antimicrobial Resistance
![Israel and the Global Equity Market](/sites/default/files/oembed_thumbnails/z9ONXNyQDvqOobmAXIcQJT3-KjvFJANVdCAwN26JmpA.jpg)
Israel and the Global Equity Market
![European Debt Crisis with Komal Sri-Kumar, Senior Fellow at Milken Institute](/sites/default/files/oembed_thumbnails/vfZLvqBxwR7dqH43ruLqW8tuLEosoPBlVdDv6NVP-ak.jpg)
European Debt Crisis with Komal Sri-Kumar, Senior Fellow at Milken Institute
![Request for Information on Improving Americans’ Access to Gene Therapies](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)
Request for Information on Improving Americans’ Access to Gene Therapies
![Mathew Wayne Whitest, MD - Stories From the Field](/themes/custom/milken_emulsify/images/default-search-thumbnail.png)